Brokerage firms Nuvama, CLSA, and Macquarie have highlighted strong growth prospects for TCS, Bajaj Finance, and IRCTC, ...

Tata Consultancy Services have 'Buy' ratings from brokers despite mixed Q3 FY25 results; discover insights on stock ...

TCS's optimistic demand outlook sparked hopes of a broader improvement in discretionary spending across the IT industry, ...

The retail sector delivered a mixed performance during the festive season, with select pockets emerging as bright spots, ...

Buoyed by signs of early demand revival, the management of TCS guided for stronger growth in CY25 and FY26 versus that seen ...

Dr. Reddy’s Laboratories shares rose 4% after Nuvama upgraded its rating to 'buy,' citing proactive strategies to mitigate ...

Nuvama assigned a target price of Rs 1,553 per share on Dr. Reddy's stock, implying an upside of 14.8% from the previous ...

The surge in Dr. Reddy's share followed an upgrade by domestic brokerage Nuvama, which raised its rating on the stock to 'Buy ...

Shares of TCS surged 4.7% after reporting a 12% rise in Q3 net profit to Rs 12,380 crore. Revenue grew 5.6% YoY, driven by ...

Dr Reddy’s share price rose nearly 4% after Nuvama Institutional Equities upgraded its rating to ’Buy’ with a target of ...

TCS valuations stay attractive compared with peers Infosys Ltd and HCL Technologies Ltd, analysts said as they suggested 'Buy ...

Nomura, on January 6, upgraded SBI Card share to ‘Buy’ from ‘Reduce’ on rising share of top metro cities in its new card ...